Abstract
Single-centre retrospective analysis of prognostic scores by the Royal Marsden Hospital (RMH) and the Gustave Roussy Institute (GRIm) in a Nottinghamshire population treated with immunotherapy for advanced non-small cell lung cancer (NSCLC)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have